Drug Profile
Research programme: arthritis therapeutic - Eyegene
Alternative Names: Degenerative arthritis therapeutic - Eyegene; Osteoarthritis therapeutic - EyegeneLatest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator EyeGene
- Class Gene therapies
- Mechanism of Action Gene expression modulators; Homeodomain protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for research development in Osteoarthritis in South Korea
- 01 Jan 2014 Early research in Osteoarthritis in South Korea (unspecified route)